Nektar Therapeutics has announced a one-for-fifteen reverse stock split of its common stock, set to take effect on June 8, 2025, at 11:59 p.m. Eastern Time. Trading on a split-adjusted basis will commence on June 9, 2025, under the existing ticker "NKTR" and a new CUSIP number 640268306. The reverse stock split will consolidate every fifteen shares of common stock into one share, with adjustments made for fractional shares.
Disclaimer: This news brief was created by Public Technologies (PUBT) using generative artificial intelligence. While PUBT strives to provide accurate and timely information, this AI-generated content is for informational purposes only and should not be interpreted as financial, investment, or legal advice. Nektar Therapeutics published the original content used to generate this news brief via EDGAR, the Electronic Data Gathering, Analysis, and Retrieval system operated by the U.S. Securities and Exchange Commission (Ref. ID: 0001213900-25-051191), on June 04, 2025, and is solely responsible for the information contained therein.